# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-26-036268
Filing Date
2026-08-06
Accepted
2026-08-06 08:20:41
Documents
46
Period of Report
2026-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 130221
2 | EX-2.1 | ex2-1.htm | EX-2.1 | 717037
3 | EX-3.1 | ex3-1.htm | EX-3.1 | 10592
4 | EX-3.2 | ex3-2.htm | EX-3.2 | 105274
5 | EX-10.1 | ex10-1.htm | EX-10.1 | 307095
6 | EX-10.2 | ex10-2.htm | EX-10.2 | 128386
7 | EX-10.3 | ex10-3.htm | EX-10.3 | 137312
8 | EX-10.4 | ex10-4.htm | EX-10.4 | 55276
9 | EX-99.1 | ex99-1.htm | EX-99.1 | 34334
10 | EX-99.2 | ex99-2.htm | EX-99.2 | 25201
11 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 53761
12 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 238235
13 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 120316
14 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 126125
15 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 176196
16 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 103268
17 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 69086
18 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 96405
19 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 96442
20 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 94443
21 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 101154
22 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 99639
23 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 164208
24 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 133412
25 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 127426
26 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 71912
27 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 94591
28 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 129645
29 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 135808
30 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 109166
31 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 116823
32 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 46866
33 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 69298
34 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 145009
35 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 121014
36 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 105119
| Complete submission text file | 0001493152-26-036268.txt |  | 6187820

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
37 | XBRL SCHEMA FILE | ensc-20260805.xsd | EX-101.SCH | 3011
38 | XBRL LABEL FILE | ensc-20260805_lab.xml | EX-101.LAB | 34239
39 | XBRL PRESENTATION FILE | ensc-20260805_pre.xml | EX-101.PRE | 22356
49 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3346

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 261246209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)